Display options
Share it on

medRxiv. 2021 Oct 18; doi: 10.1101/2021.10.15.21265063.

Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.

medRxiv : the preprint server for health sciences

Adrienne E Shapiro, Rachel A Bender Ignacio, Bridget M Whitney, Joseph A Delaney, Robin M Nance, Laura Bamford, Darcy Wooten, Jeanne C Keruly, Greer Burkholder, Sonia Napravnik, Kenneth H Mayer, Allison R Webel, H Nina Kim, Stephen E Van Rompaey, Katerina Christopoulos, Jeffrey Jacobson, Maile Karris, Davey Smith, Mallory O Johnson, Amanda Willig, Joseph J Eron, Peter Hunt, Richard D Moore, Michael S Saag, W Christopher Mathews, Heidi M Crane, Edward R Cachay, Mari M Kitahata,

PMID: 34704092 PMCID: PMC8547524 DOI: 10.1101/2021.10.15.21265063

Abstract

BACKGROUND: Understanding the spectrum of SARS-CoV-2 infection and COVID-19 disease in people with HIV (PWH) is critical to provide clinical guidance and implement risk-reduction strategies.

OBJECTIVE: To characterize COVID-19 in PWH in the United States and identify predictors of disease severity.

DESIGN: Observational cohort study.

SETTING: Geographically diverse clinical sites in the CFAR Network of Integrated Clinical Systems (CNICS).

PARTICIPANTS: Adults receiving HIV care through December 31, 2020.

MEASUREMENTS: COVID-19 cases and severity (hospitalization, intensive care, death).

RESULTS: Of 16,056 PWH in care, 649 were diagnosed with COVID-19 between March-December 2020. Case fatality was 2%; 106 (16.3%) were hospitalized and 12 died. PWH with current CD4 count <350 cells/mm

LIMITATIONS: Unable to compare directly to persons without HIV; underestimate of total COVID-19 cases.

CONCLUSIONS: PWH with CD4 <350 cells/mm

Publication Types

Grant support